Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
Recruiting
N/A
Interventional Study
Thrombopenia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 8 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 280 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Thrombocytopenia is a clinical problem defined by a platelet count lower than 150×10⁹/L. It can be linked to various pathologies of central origin, such as decreased platelet production in the bone marrow, or peripheral origin with increased platelet destruction through autoimmune mechanisms, increased splenic sequestration, or excessive platelet consumption. Significant fatigue is often reported …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria for patients (adults or minors):
* Patients with constitutional or autoimmune (chronic or persistent ITP with last treatment administration ≥ 3 weeks) thrombocytopenia (platelet count \< 150×109/L) already diagnosed
* patient not being treated and not receiving serotonin reuptake…
Contacts